Treatment of Hepatocellular Cancer Due to Hepatitis Delta with Yttrium-90 Radioembolization in a Patient with Cirrhosis: A Case Report
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.20, sa.3, ss.131-133, 2014 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20 Sayı: 3
- Basım Tarihi: 2014
- Doi Numarası: 10.4274/vhd.69775
- Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.131-133
- Anahtar Kelimeler: Hepatocellular cancer, yttrium-90, CARCINOMA, THERAPY
- İstanbul Üniversitesi Adresli: Evet
Özet
Cirrhosis due to delta hepatitis is one of the most important etiologic factors in our country. Hepatocellular carcinoma (HCC) often develops on the base of cirrhosis. Recently, yttrium-90 radioembolization therapy has been increasingly used in the treatment of HCC. Transarterial infusion of yttrium-90 radioactive microspheres is a new promising method in treating unresectable liver tumors. Herein, we present a 55-year-old male HCC patient who developed HCC due cirrhosis associated with delta hepatitis and was successfully treated with yttrium-90 radioembolization therapy.